Are you ready to feel the energy of ESC Congress 2023?
We’re excited to share the first release of this year’s scientific programme, including the NEW ESC Clinical Practice Guidelines sessions.
Discover the latest and greatest advances in your field, during educational sessions delivered by your peers and cardiology heroes.
Valvular diseases are a leading cause of morbidity and mortality around the world. The ultimate reparative therapy for almost all clinically significant valvular diseases is interventional, however, less attention is given to patients whose VHD is not considered severe enough for intervention.
At the ESC, we understand that our members need more from us than the latest science.
That’s why we work hard to provide our Professional Members with an exciting range of support for their professional development, so they have everything they need to deliver the best patient care possible.
In the last few years, COVID-19 has emerged as an important aetiology of myocarditis, from both direct infection and immune reactions. It has also been connected to a reaction to specific SARS-CoV-2 vaccines. This makes it an especially timely subject for this Topic of the Month.
Put your work, your team and your institution centre stage by submitting your abstract by 1 March.
This summer, in Amsterdam, gain international recognition and unrivalled exposure for your research, while joining forces with peers to advance cardiovascular science together.
Pulmonary hypertension is a cause for major morbidity and mortality, and while therapeutic options are evolving, they are still limited and difficult to administer. Following the publication of these new guidelines at ESC Congress 2022, we have three on-demand webinars on this subject.
Get a summary of the year’s most exciting and top-cited articles from the ESC journal family in a handful of great presentations. They’re free to access on ESC 365 for the month of December and cover topics from cardio-oncology and dyslipidaemias, to the digitisation of CV care.